InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (6 ops.)
Explore the full record of transactions filed by PERRY MICHAEL S, Director. Officer active across 2 companies, notably Arrowhead Pharmaceuticals, INC.. In total, 14 disclosures have been published. Total volume traded: €2.7m. The latest transaction was filed on 5 December 2025 — Cession. Regulator: SEC (Form 4). The full history is openly available.
Declarations14 total
US$851,80316,250 shares@ US$52.41870.0079% mcap85.1% of flow
Common Stock
SEC:0001250379-25-000003·
€851,80316,250 shares@ €52.41870.0079% mcap42.6% of flow
Common Stock
SEC:0001250379-25-000003:0·
023,754 shares0
Common Stock
SEC:0001209191-22-033585:0·
023,753 shares0
Common Stock
SEC:0001209191-22-013222:0·
06,400 shares0
Common Stock
SEC:0001209191-22-002595·
06,400 shares0
Common Stock
SEC:0001209191-22-002595:0·
€148,5742,628 shares@ €56.53510.0014% mcap14.9% of flow
Common Stock
SEC:0001209191-22-001318·
€148,5742,628 shares@ €56.53510.0014% mcap7.4% of flow
Common Stock
SEC:0001209191-22-001318:0·
23,800 shares
Common Stock
SEC:0001209191-21-071256·
23,800 shares
Common Stock
SEC:0001209191-21-071256:0·
023,754 shares0
Common Stock
SEC:0001209191-21-054958·
023,754 shares0
Common Stock
SEC:0001209191-21-054958:0·
€326,44923,000 shares@ €14.19340.31% mcap100.0% of flow
Common Stock
SEC:0001209191-21-038189·
€326,44923,000 shares@ €14.19340.31% mcap50.0% of flow
Common Stock
SEC:0001209191-21-038189:0·
14 of 14 declarations
About PERRY MICHAEL S
PERRY MICHAEL S serves as Chief Executive Officer of ARROWHEAD PHARMACEUTICALS, INC. and AVITA Medical, Inc. He oversees the overall operations and strategy of these companies, focusing on innovation in the healthcare sector. With extensive experience in the biopharmaceutical industry, he is responsible for guiding teams towards achieving strategic objectives and maximizing shareholder value. His leadership is essential for navigating a competitive environment.
